Authors:
MANSOUR EG
GRAY R
SHATILA AH
TORMEY DC
COOPER MR
OSBORNE CK
FALKSON G
Citation: Eg. Mansour et al., SURVIVAL ADVANTAGE OF ADJUVANT CHEMOTHERAPY IN HIGH-RISK NODE-NEGATIVE BREAST-CANCER - 10-YEAR ANALYSIS - AN INTERGROUP STUDY, Journal of clinical oncology, 16(11), 1998, pp. 3486-3492
Citation: Bj. Averbook et al., A LONG-TERM ANALYSIS OF 620 PATIENTS WITH MALIGNANT-MELANOMA AT A MAJOR REFERRAL CENTER, Surgery, 124(4), 1998, pp. 746-756
Authors:
MARTENSON JA
LIPSITZ SR
WAGNER H
KAPLAN EH
OTTEMAN LA
SCHUCHTER LM
MANSOUR EG
TALAMONTI MS
BENSON AB
Citation: Ja. Martenson et al., INITIAL RESULTS OF A PHASE-II TRIAL OF HIGH-DOSE RADIATION-THERAPY, 5-FLUOROURACIL, AND CISPLATIN FOR PATIENTS WITH ANAL CANCER (E4292) - AN EASTERN-COOPERATIVE-ONCOLOGY-GROUP STUDY, International journal of radiation oncology, biology, physics, 35(4), 1996, pp. 745-749
Authors:
CLARK JL
KUCUK O
NEUBERG DS
BENSON AB
TAYLOR SG
PANDYA KJ
MANSOUR EG
DOUGLASS HO
HALLER DG
Citation: Jl. Clark et al., PHASE-II TRIAL OF ETOPOSIDE, DOXORUBICIN, AND CISPLATIN COMBINATION IN ADVANCED MEASURABLE GASTRIC-CANCER - AN EASTERN-COOPERATIVE-ONCOLOGY-GROUP STUDY, American journal of clinical oncology, 18(4), 1995, pp. 318-324
Authors:
GALE KE
ANDERSEN JW
TORMEY DC
MANSOUR EG
DAVIS TE
HORTON J
WOLTER JM
SMITH TJ
CUMMINGS FJ
Citation: Ke. Gale et al., HORMONAL TREATMENT FOR METASTATIC BREAST-CANCER - AN EASTERN-COOPERATIVE-ONCOLOGY-GROUP PHASE-III TRIAL COMPARING AMINOGLUTETHIMIDE TO TAMOXIFEN, Cancer, 73(2), 1994, pp. 354-361
Authors:
ADELSTEIN DJ
KALISH LA
ADAMS GL
WAGNER H
OKEN MM
REMICK SC
MANSOUR EG
HASELOW RE
Citation: Dj. Adelstein et al., CONCURRENT RADIATION-THERAPY AND CHEMOTHERAPY FOR LOCALLY UNRESECTABLE SQUAMOUS-CELL HEAD AND NECK-CANCER - AN EASTERN-COOPERATIVE-ONCOLOGY-GROUP PILOT-STUDY, Journal of clinical oncology, 11(11), 1993, pp. 2136-2142
Authors:
ALLRED DC
CLARK GM
TANDON AK
MOLINA R
TORMEY DC
OSBORNE CK
GILCHRIST KW
MANSOUR EG
ABELOFF M
EUDEY L
MCGUIRE WL
Citation: Dc. Allred et al., HER-2 NEU IN NODE-NEGATIVE BREAST-CANCER - PROGNOSTIC-SIGNIFICANCE OFOVEREXPRESSION INFLUENCED BY THE PRESENCE OF INSITU CARCINOMA/, Journal of clinical oncology, 10(4), 1992, pp. 599-605